2015 Competition Prescription 
Pharmaceutical Technology
DECEMBER 22, 2022
Theft, fraudulent prescriptions and unsanctioned distribution by patients and medical practitioners are the most common ways in which legal fentanyl products are illegally secured. According to the National Institute of Drug Abuse, the total number of drug-involved overdose deaths in the US increased from 52,404 in 2015 to 91,799 in 2020.
pharmaphorum
JULY 15, 2022
Teva launched its first generic in that year with a skinny label that excluded the heart failure use, as it was covered by a use patent that expired in 2015. The substance patent expired in 2007. The post Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
MAY 15, 2023
Because nearly all prescriptions are now written electronically. For example, starting in 2015 at Ogilvy, I watched companies that had been using print materials in doctors’ offices begin switching to large electronic tablets in waiting and exams rooms that displayed information for multiple brands.
Pharmaceutical Technology
OCTOBER 25, 2022
Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Of those 131 approved FDCs, 98 were oral dosage forms.
Referral MD
MAY 4, 2022
Today’s healthcare practitioner must realize that the business of healthcare is a competitive one and it is only through proactively marketing your services to existing and new patients that you will improve your bottom line. These features include: Tools for managing patient interactions, such as appointments, prescriptions, and more.
Pharmaceutical Technology
JULY 23, 2008
Between 2003 and 2005 global sales for cancer-treating drugs grew by 40% According to IMS Health, who tracks prescription drug sales, the global market for cancer drugs is still growing rapidly with around $48bn spent on oncology products in 2008; a figure which accounts for 17% of worldwide pharmaceutical sales. .”
Pharmaceutical Technology
JANUARY 6, 2023
The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.
Expert insights. Personalized for you.
105 
Let's personalize your content